Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Related Posts Investing in Graphene Companies September 18, 2025 Gold Price Breaks US$3,700, Then Falls as Fed Cuts Rates September 18, 2025 Lo Herma Hydrogeology Testing & Resource Expansion Drilling September 18, 2025